Rest-redistribution thallium-201 myocardial scintigraphic study in cardiac amyloidosis

International Journal of Cardiac Imaging

Volumn 15, Issue 5, 1999, Pages 371-378

  Kodama, Koji ^a   Hamada, Mareomi ^b   Kuwahara, Taishi ^b   Nakamura, Michitsugu ^b   Shigematsu, Yuji ^b   Hiwada, Kunio ^b   Iwata, Takeru ^b   Hoshii, Yoshinobu ^b   Ishihara, Tokuhiro ^b  

^a Yawatahama General Hospital   (Japan)

^b NONE

Author keywords

Cardiac amyloidosis; Reverse redistribution; Thallium clearance

Indexed keywords

AMYLOID PROTEIN; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FEMALE; HEART AMYLOIDOSIS; HEART INFARCTION; HEART SCINTISCANNING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUSCLE CELL; RADIOCARDIOGRAPHY; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AMYLOIDOSIS; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 0032716463     PISSN: 01679899     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006210913708     Document Type: Article

References (23)

1. Sipe JD, Cohen AS. Amyloidosis. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al. (eds). Harrison's Principle of Internal Medicine, 14th edition. New York: McGraw-Hill, Inc., 1998: 1856-1860.
2. Wizenberg TA, Muz J, Sohn YH, Samlowski W, Weissler AM. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis. Am Heart J 1982; 103: 468-473.
3. Sobol SM, Brown JM, Bunker SR, Patel J, Lull RJ. Non-invasive diagnosis of cardiac amyloidosis by technetium-99m-pyrophosphate myocardial scintigraphy. Am Heart J 1982; 103: 563-566.
4. Hartmann A, Frenkel J, Hopf R, Baum RP, Hör G, Schneider M, et al. Is technetium-99m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis. Int J Card Imaging 1990; 5: 227-231.
5. Ohta H, Endo K, Kanoh T, Konishi J, Kotoura H. Technetium-99m (V) DMSA uptake in amyloidosis. J Nucl Med 1989; 30: 2049-2052.
6. 123I-labeled serum amyloid P component. N Engl J Med 1990; 323: 508-513.
7. Lekakis J, Dimopoulos M, Nanas J, Prassopoulos V, Agapitos N, Alexopoulos g, et al. Antimyosin scintigraphy for detection of cardiac amyloidosis. Am J Cardiol 1997; 80: 963-965.
8. Weiss AT, Maddahi J, Lew AS, Shah PK, Ganz W, Swan HJC, et al. Reverse redistribution of thallium-201: a sign of nontransmural myocardial infarction with patency of the infarct-related coronary artery. J Am Coll Cardiol 1986; 7: 61-67.
9. Pace L, Cuocolo A, Marzullo P, Nicolai E, Gimelli A, Luca ND, et al. Reverse redistribution in resting thallium-201 myocardial scintigraphy in chronic coronary artery disease: an index of myocardial viability. J Nucl Med 1995; 36: 1968-1973.
10. Falk RH, Plehn JF, Deering T, Schick EC Jr, Boinay P, Rubinow A, et al. Sensitivity and specificity of the echo-cardiographic features of cardiac amyloidosis. Am J Cardiol 1987; 59: 418-422.
11. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
12. Chang L-T. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; NS-25: 638-643.
13. Smith TJ, Kyle RA, Lie JT. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc 1984; 59: 547-555.
14. Liu P, Burns RJ. Easy come, easy go: time to pause and put thallium reverse redistribution in perspective. J Nucl Med 1993; 34: 1692-1694.
15. Leppo JA, Okada RD, Strauss HW, Pohost GM. Effect of hyperaemia on thallium-201 redistribution in normal canine myocardium. Cardiovasc Res 1985; 19: 679-685.
16. Grunwald AM, Watson DD, Holzgrefe HH Jr, Irving JF, Beller GA. Myocardial thallium-201 kinetics in normal and ischemic myocardium. Circulation 1981; 64: 610-618.
17. Soeki T, Fukuda N, Shinomiya H, Takeichi N, Shinohara H, Yui Y, et al. A case of cardiac amyloidosis demonstrating a severe impairment of coronary flow reserve and left atrial function. Jpn J Med Ultrasonics 1996; 23: 809-814.
18. Takezaki M, Ishida Y, Morozumi T, Tani A, Sato H, Hori M, et al. Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate myocardial scintigraphy in 2 cases with familial amyloid polyneuropathy and 1 case with secondary amyloidosis. Jpn J Nucl Med 1989; 26: 1537-1543.
19. Tanaka M, Hongo M, Kinoshita O, Takabayashi Y, Fujii T, Yazaki Y, et al. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy. J Am Coll Cardiol 1997; 29: 168-174.
20. Smith RRL, Hutchins GM. Ischemic heart disease secondary to amyloidosis of intramyocardial arteries. Am J Cardiol 1979; 44: 413-417.
21. Narang R, Chopra P, Wasir HS. Cardiac amyloidosis presenting as ischemic heart disease. Cardiology 1993; 82: 294-300.
22. Marin-Neto JA, Marzullo P, Marcassa C, Gallo L Jr, Maciel BC, Bellina R, et al. Myocardial perfusion abnormalities in chronic Chagas' disease as detected by thallium-201 scintigraphy. Am J Cardiol 1992; 69: 780-784.
23. Fields CL, Ossorio MA, Roy TM, Denny DM, Varga DW. Thallium-201 scintigraphy in the diagnosis and management of myocardial sarcoidosis. South Med J 1990; 83: 339-342.